Grifols Promonitor®

The Promonitor^® product portfolio is manufactured by Grifols and distributed by Aidian. Promonitor^® biological drug monitoring tests offer key information about drug bioavailability and immunogenicity in patients prescribed with biological therapy for the treatment of chronic inflammatory diseases and other indications.

Promonitor^® ELISA tests allow determination of biologic drug concentration and anti-drug antibody level in serum. The following biological treatments can be tested: infliximab, adalimumab, etanercept, rituximab, golimumab, vedolizumab and ustekinumab.